Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (741-750 of 818) with videos related to

Pageof 82
Sort By:
Annals of Surgery|September 1, 1982
Depressed high-energy phosphate content in hypertrophied ventricles of animal and man: the biologic basis for increased sensitivity to ischemic injuryR B Peyton, R N Jones, D Attarian, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1980
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 1997
Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance programW W Wilke, S A Marshall, S L Coffman, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1981
Metabolic deterioration during global ischemia as a function of time in the intact normal dog heartR N Jones, D E Attarian, W D Currie, et al.
Journal of Clinical Microbiology|January 9, 2003
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformansT Yamazumi, M A Pfaller, S A Messer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1987
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivoA L Barry, G H Miller, C Thornsberry, et al.
Circulation Research|October 1, 1981
The coronary pressure-flow determinants left ventricular compliance in dogsC O Olsen, D E Attarian, R N Jones, et al.
Pageof 82

Showing results (741-750 of 818) with videos related to

Sort By:
Pageof 82
Annals of Surgery|September 1, 1982
Depressed high-energy phosphate content in hypertrophied ventricles of animal and man: the biologic basis for increased sensitivity to ischemic injuryR B Peyton, R N Jones, D Attarian, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1980
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 1997
Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance programW W Wilke, S A Marshall, S L Coffman, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1981
Metabolic deterioration during global ischemia as a function of time in the intact normal dog heartR N Jones, D E Attarian, W D Currie, et al.
Journal of Clinical Microbiology|January 9, 2003
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformansT Yamazumi, M A Pfaller, S A Messer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1987
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivoA L Barry, G H Miller, C Thornsberry, et al.
Circulation Research|October 1, 1981
The coronary pressure-flow determinants left ventricular compliance in dogsC O Olsen, D E Attarian, R N Jones, et al.
Pageof 82